Overall, our study revealed that CRC-derived exosomal ADAM17 effectively blocks VE-cadherin-mediated adhesion to vascular endothelial cells, thereby increasing endothelial barrier permeability and enhancing tumor cell metastasis. This evidence concerns the gene ADAM17 and neoplasm.